Covid vaccines: France expects 300,000 more doses than expected by June

As the weeks went by, the increase in production capacity of the laboratories was confirmed.

In its latest forecast published on Wednesday, the Directorate General of Health (DGS) expects to receive, in June, 300,000 more doses than expected so far.

100,000 additional doses of Janssen and 200,000 doses of AstraZeneca are expected.

To read also: Vaccination: these thousands of niches which do not find a taker in France

The increase in AstraZeneca hoped for in June will come after a drop of 300,000 doses in May compared to forecasts of last week.

The laboratory therefore expects to make up for this delay and to send more doses to France.

Deliveries from Pfizer and Moderna, meanwhile, remain unchanged from forecasts last week.

Thanks to these increases, France should have received, at the end of June, more than 77.2 million doses of vaccines, of which 62% from Pfizer, 19% from AstraZeneca, 10.3% from Moderna and 8.7% from Janssen .

The next hoped-for marketing authorization, that of Curevac, is not expected until July, and that of the Sanofi-GSK vaccine at the end of the fourth quarter.

Evolution of monthly dose deliveries, in millions of cumulative doses since December Le Figaro, DGS data

The increase in deliveries is particularly noticeable in the second quarter: while France had received only 500,000 doses in December and 2.2 million in January, this number rose to 8.6 million in March, 12.5 million in April and 16.7 million in May, according to the DGS.

These increases in deliveries lead the Ministry of Health to confirm the objectives put forward so far by the executive, ie 20 million first injections in mid-May and 30 million in mid-June. At this date, "

", wants to believe the ministry. Subject to multiple delays in deliveries as well as criticism for its few side effects, the AstraZeneca vaccine remains, for the time being, essential, "

" of target populations. , we note at the ministry.